Predictions of Oncotype DX® High-Risk Classification Using Magnetic Resonance Imaging-Based Intratumoral Heterogeneity
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q2Scopus Q3
- 저널
- BIOENGINEERING-BASEL13(6) · 2026
- 피인용
- Web of Science 0Scopus 0
- FWCI (Scopus)
- 0
- JCR IF
- JCR 2024 3.7
- ISSN
- 2306-5354
저자
- Park, Sung Joon제1저자Kyungpook Natl Univ, Sch Comp Sci & Engn, Daegu 41566, South Korea
- Kim, Won HwaBeamWorks Inc, Daegu 41566, South Korea
- Kim, JaeilKyungpook Natl Univ, Sch Comp Sci & Engn, Daegu 41566, South Korea
- 강태우Pusan Natl Univ, Sch Med, Dept Surg, Busan 49241, South Korea
- Park, Ji-YoungKyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Pathol, Daegu 41404, South Korea
- Kang, ByeongjuKyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Surg, Daegu 41404, South Korea
- Moon, Joon SukKyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Surg, Daegu 41404, South Korea
- Park, Ho YongKyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Surg, Daegu 41404, South Korea
- Kim, Hye JungKyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Radiol, Daegu 41404, South Korea
- Lee, Jeeyeon교신저자Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Surg, Daegu 41404, South Korea
초록
The Oncotype DX® 21-gene recurrence score (RS) guides adjuvant chemotherapy decisions in estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2−) breast cancer, yet requires invasive tissue sampling and involves substantial costs. This study evaluated intratumoral tumor ecological diversity (iTED), a habitat imaging approach, as a non-invasive complement for predicting Oncotype DX® high-risk classification (RS > 25). This retrospective multi-center study included 312 patients with ER+/HER2− invasive breast cancer who underwent Oncotype DX® testing (development: n = 168; external validation: n = 144). The iTED framework employed superpixel-based habitat determination using Gaussian mixture models on pretreatment dynamic contrast-enhanced MRI. Four predictive models were compared: clinical, conventional whole-tumor radiomics (C-radiomics), iTED, and combined (Clinical + iTED). The iTED model achieved higher discriminative performance compared with C-radiomics in both development (area under the curve [AUC]: 0.868 ± 0.068 vs. 0.730 ± 0.112) and external validation (AUC: 0.811 vs. 0.587) sets. The combined model further improved performance (development AUC: 0.908 ± 0.043; external AUC: 0.889). Habitat imaging-based iTED features achieved numerically higher performance than conventional radiomics in predicting Oncotype DX® high-risk classification. These findings suggest the potential of iTED as a non-invasive imaging biomarker to support molecular testing in clinical decision-making.
키워드
breast cancerdynamic contrast-enhanced magnetic resonance imaginghabitat imagingintratumoral heterogeneityiTEDOncotype DX®radiomics
식별자
- Scopus EID
- 2-s2.0-105042901996
- WoS UID
- 001804284300001



로그인
연구물 목록으로